---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Atomwise

🌎 atomwise.com

Atomwise is a preclinical pharma company revolutionizing drug discovery through artificial intelligence. The company has developed AtomNet®, a deep learning technology that enables the discovery of small-molecule drug candidates for challenging disease targets. With over 250 partners globally, Atomwise is focused on advancing its internal pipeline and has raised significant funding to support its mission of delivering better medicines faster.

---

Atomwise - Latest News and Updates

• Atomwise is currently seeking a Director/Senior Director of Project Management in the United States.
• Atomwise is identified as a key player in the AI-generated enzymes market, which is projected to reach USD 19,407.75 million by 2034.
• Atomwise is hiring for remote positions including a Machine Learning Research Scientist/Engineer and a Cheminformatician for their drug discovery platform.
• Atomwise collaborated with Thoth Biosimulations to develop novel inhibitors for RMT1 that target hTERT-overexpressing cancer cells.
• Atomwise uses deep learning to predict binding affinity between drug candidates and target proteins for diseases like leukaemia and Ebola.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.